Zacks.com on MSN13d
CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary GoalShares of Candel Therapeutics CADL surged 68.1% on Wednesday after the company reported superior efficacy of CAN-2409, an ...
The 20 analysts covering Palantir have a 12-month median price target of $38, which would be a 46% drop from current levels. If that does indeed happen, its valuation could drop big time in the coming ...
The Lions have weathered unparalleled bad luck with their injuries, but Sunday's loss to the Bills showed Detroit could be in ...
Clayton Keller gave Utah life when he rebounded a Nick Schmaltz shot with just under 11 minutes remaining and quickly flicked ...
Ava Arndt and Ivy Jensen team up with Kamloops sisters to win B.C. U18 finals in Kimberley; advance to nationals in Saskatoon ...
Sports' national scouting team provides our top performers from the four-day state championship extravaganza at AT&T Stadium.
It’s also the fourth-largest guaranteed deal ever for a pitcher, trailing ... of club control remaining and won’t be eligible ...
Century wrestling took the final two bouts of Tuesday’s dual at Glenelg, including Grady Faye’s pin in the final bout, to ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback